Eliminating Inter-Segment Sales

When a conglomerate operates multiple divisions under one corporate umbrella, they often buy from and sell to each other. A semiconductor company's chip division may supply a consumer electronics division. A pharmaceutical company's manufacturing division may produce active pharmaceutical ingredients for its branded and generic drug divisions. A media company's content division may license shows to its streaming and traditional broadcast divisions.

These transactions are real—cash moves, goods transfer—but they create a critical valuation challenge: if you sum the revenues of all segments, you are double-counting. A dollar of revenue in the supplier segment is also recorded as a dollar of cost (or revenue) in the buyer segment. Without careful adjustment, your sum-of-the-parts valuation will overstate the company's true economic value.

This article explains how to identify, quantify, and eliminate inter-segment transactions to arrive at accurate stand-alone segment valuations.

Quick definition: Inter-segment transactions are sales of products, services, or intellectual property between divisions of the same company. When valued independently, these transactions must be eliminated to avoid double-counting revenue and distorting segment profitability.

Key Takeaways

• Intersegment revenue is disclosed in the segment footnote of the 10-K; start there and work backward to adjust segment financials.
• The price at which one segment sells to another (transfer price) may not reflect market rates, creating profit distortion; market-price adjustment is often necessary.
• Elimination of intersegment sales reduces consolidated revenue but also eliminates intersegment costs, affecting segment margins differently.
• Synergies created by internal transactions (lower transfer prices, preferential access) must be quantified and separately valued; they will be lost in a spin-off scenario.
• Some intersegment transactions are unavoidable in standalone scenarios; others are entirely conglomerate-specific and must be zeroed out.
• Consistency in elimination across all segments is essential; incomplete elimination in one area will cascade into valuation errors elsewhere.

Where to Find Intersegment Transactions

Companies must disclose intersegment revenue under FASB Topic 280. Look for this in the segment footnote (typically Note 17, 18, or 19 of the 10-K), usually in a table showing:

• External revenue (sold to third parties)
• Intersegment revenue (sold to other segments)
• Total revenue (external + intersegment)

Here's a simplified example:

Segment	External Revenue	Intersegment Revenue	Total Revenue
Chips	$8,000M	$1,200M	$9,200M
Devices	$12,000M	$500M	$12,500M
Services	$3,500M	$300M	$3,800M
Total	$23,500M	$2,000M	$25,500M

The Chips segment sold $1,200 million to other segments (primarily to Devices, which uses chips as a component). When you value these segments stand-alone, you cannot include that $1,200 million in Chips' revenue; it will be replaced by sales to external customers or simply will not exist (if the device segment is divested).

Why Transfer Pricing Matters

Intersegment transactions are priced through a mechanism called transfer pricing. In theory, transfer prices should reflect market rates—what the supplier could charge an external customer and what the buyer could pay an external supplier. In practice, transfer prices are often:

• Cost-plus pricing: The supplier charges cost plus a markup (e.g., 15% above cost).
• Cost sharing: The supplier charges only the incremental cost with no profit margin.
• Negotiated pricing: The two divisions negotiate a price that reflects both internal and market factors.

This matters for SOTP valuation because the transfer price affects how profits are allocated. If Chips sells to Devices at cost-plus 10%, and Devices could buy from an external supplier at cost-plus 25%, then Chips is subsidizing Devices' profit margin by 15 percentage points. When Devices is valued stand-alone, it will face higher input costs and lower margins unless it negotiates better terms with external suppliers.

Example: A pharmaceutical company's manufacturing division sells active pharmaceutical ingredients to the branded drugs division at cost plus 5%. External suppliers charge cost plus 20%. When the branded drugs division is valued as a standalone entity, its future EBITDA will be 15 percentage points lower than what it currently shows, because it will lose the captive supplier's below-market pricing.

To adjust for this, you must:

1. Identify the transfer price.
2. Identify the market price for equivalent inputs.
3. Revalue segment EBITDA using market-equivalent pricing.

The company rarely discloses transfer prices explicitly; you must infer them from the intersegment revenue and the nature of the products/services being transferred. Conversations with management on the earnings call or in meetings with analysts sometimes provide hints.

The Mechanics of Elimination

Eliminating intersegment revenue has three steps:

Step 1: Identify the supplier and buyer segments.

From the segment footnote, determine which segment sold to which. Chips sold to Devices; Manufacturing sold to Branded Drugs. Sometimes a segment sells to multiple others; map out the full network.

Step 2: Remove the intersegment revenue from the supplier segment.

Chips' reported external revenue is $8,000 million and intersegment revenue is $1,200 million. For SOTP purposes, Chips' stand-alone revenue is $8,000 million (unless the Devices segment would continue to buy chips elsewhere). That $1,200 million should be zero'd out; it's not revenue that would exist post-spin.

Step 3: Ensure the buyer's costs are adjusted appropriately.

If Devices "purchased" $1,200 million in chips internally but will buy from external suppliers post-spin at a higher cost, Devices' cost of goods sold will increase. This increases the COGS and decreases operating margin for Devices.

But wait—if you eliminate the supplier segment's revenue and the buyer segment's internal supply, the buyer will need to source that product externally. The external price is typically higher. So:

• Supplier segment stand-alone revenue: Down by intersegment amount.
• Buyer segment stand-alone COGS: Up by the difference between external market price and the transfer price charged.
• Net effect: The company's consolidated economic profit is unchanged, but its segment-by-segment breakdown shifts.

Handling Synergies and Preferential Access

Intersegment transactions sometimes reflect synergies that would not be available in a truly stand-alone scenario. Examples:

• A captive supplier that operates at a lower cost than external competitors because it achieves scale through serving internal customers.
• A captive distribution channel that gives one segment preferential access to customers.
• Exclusive licensing of intellectual property between segments.

When you eliminate intersegment transactions, you are inherently assuming the segments will source elsewhere. But if the captive supplier is the most efficient, eliminating the transaction understates value.

The correct approach: Value the segments using external market dynamics (external suppliers, external distribution), then separately quantify the synergy value. The synergy becomes part of the conglomerate premium (or discount). If conglomerate synergies are worth $500 million but would be lost in a spin, the sum of stand-alone valuations should be adjusted upward by $500 million to value the intact whole; alternatively, subtract $500 million from the intact valuation to arrive at standalone segment values.

This is an area where judgment matters. If a segment's internal supplier is genuinely the low-cost provider in the market, you might assume 50% of the internal volume continues post-spin (because the supplier can still win that business in a competitive market). If the internal supplier is mediocre and exists only because it's captive, you assume 0% of volume continues.

Segment-Specific Adjustments

For the supplier segment:

• Revenue: Remove intersegment revenue.
• COGS and operating expenses: No change (the supplier still incurred these costs to produce goods sold internally).
• EBITDA margin: Likely to decline because fixed costs are now spread over lower revenue.

For the buyer segment:

• Revenue: Typically no change; external revenue is unaffected.
• COGS: Increase if external suppliers charge more than the internal transfer price.
• Operating margin: Decline as a result of higher COGS.

For segments in the middle (both buying and selling internally):

• Remove both intersegment revenue and intersegment purchases.
• The net impact on margin depends on whether the segment is a net buyer or seller and whether the markup is positive or negative.

Real-World Examples

Berkshire Hathaway: While not formally segmented for reporting, Berkshire's insurance operations generate massive float that is deployed across all other subsidiaries. This is a conglomerate-specific benefit. If Berkshire's insurance business were spun off, the parent company would lose access to this low-cost capital and would need to fund acquisitions differently. This represents a significant synergy that would be lost post-spin and is a reason why Berkshire, valued as a whole, commands a premium to the sum of its parts.

General Electric (pre-2021): GE's Power, Renewable Energy, and Aviation segments purchased components and services from each other. GE Power sold turbine components to Renewable Energy and Aviation. Additionally, GE's internal financing business (GE Capital) provided favorable terms to all segments. When GE began spinning off divisions, the losing business had to source components externally at higher cost and access capital at market rates, which reduced margins compared to the all-in-one valuations.

Johnson & Johnson: J&J's Innovative Medicines segment often uses Active Pharmaceutical Ingredients (APIs) manufactured by J&J subsidiaries rather than external suppliers. The Consumer Health segment licenses formulations from other segments. Eliminating these internal transactions significantly reduces the revenue of the API supplier segments but increases the COGS of the downstream segments. The market price of APIs is typically higher than J&J's internal transfer price.

DuPont (pre-spin): DuPont sold specialty materials to its own Electronics & Imaging segment. These materials were critical components; external suppliers existed but charged premium prices because DuPont's specification requirements were unique. Valuing Electronics & Imaging as standalone required assuming either higher COGS (using external supplier prices) or a synergy adjustment (assuming continued access to DuPont materials at favorable pricing).

Common Mistakes

1. Removing intersegment revenue from the supplier but forgetting to adjust the buyer's costs. If you eliminate Chips' $1,200 million in internal sales, you must also adjust Devices' COGS to reflect the cost of external chips. Failing to do so creates a reconciliation error in the consolidated valuation.

2. Assuming all intersegment transactions disappear. Some transactions are so critical (e.g., a manufacturing segment that is the sole supplier of a critical component) that the buyer would negotiate continued supply even post-spin. These are not pure eliminations; they're market-price adjustments.

3. Ignoring transfer pricing volatility. Transfer prices sometimes change year-to-year based on internal cost movements. Use normalized transfer prices based on a multi-year average, not a single-year outlier.

4. Failing to track the downstream impact. Intersegment transactions sometimes flow through multiple segments. If Segment A sells to B, which processes and sells to C, eliminating A-to-B without considering B-to-C will create inconsistencies.

5. Conflating intersegment transactions with shared costs. Shared corporate costs (finance, legal, IT) are not transactions; they're allocations. Intersegment transactions are actual sales. Do not confuse the two when adjusting segment financials.

Frequently Asked Questions

Q: Should I eliminate 100% of intersegment transactions or only some? A: It depends on whether the transaction would survive post-spin. If the buyer could source elsewhere and would do so, eliminate 100%. If the transaction represents a critical supply relationship that would likely continue post-spin (with potentially different pricing), assume the volume continues but adjust the price to market rates.

Q: How do I determine the market price for an intersegment transaction when the product is proprietary? A: Look for comparable products sold by external suppliers to external customers. If no direct comparable exists, survey industry reports, pricing guides (e.g., chemical pricing indices), or consult industry contacts. Benchmark the price as a percentage above/below the company's disclosed cost of goods sold.

Q: What if the company does not disclose intersegment transactions in enough detail? A: Use the MD&A, earnings call transcript, and investor presentations for clues. Ask the IR team directly; they often provide breakdowns beyond what's in the footnote. Examine consolidated revenue and segment external revenue to back-calculate intersegment amounts.

Q: If a segment is entirely internal (only sells to other segments), how do I value it? A: You do not value it separately. An entirely internal segment is a cost center or shared service provider. Its economic value is its contribution to the downstream segments' profitability. Adjust those downstream segments' margins for the fair-market cost of outsourcing the internal service.

Q: Should I adjust historical intersegment prices for inflation? A: Only if you're comparing intersegment transactions across multiple years and inflation has been significant. For current valuations, use the current intersegment price as disclosed; if you believe external market prices have moved, benchmark against current external quotes.

Q: How do I handle a segment that is both a significant buyer and seller internally? A: Calculate net intersegment flow. If Segment A buys $500M from B and sells $300M to B, the net is $200M incoming from B. Eliminate both the gross amounts and measure the net impact on A's profitability.

Related Concepts

• Transfer Pricing Regulations: Tax authorities (IRS, OECD) mandate that transfer prices between related entities reflect arm's-length pricing. This provides a regulatory anchor for your assumptions.
• Comparable Uncontrolled Price (CUP): A transfer pricing method that uses prices charged between unrelated parties for similar transactions. This is a standard reference point for your adjustments.
• Synergy Valuation: The quantification of value that is created by internal transactions but would be lost post-spin. Often valued as a separate line item.
• Segment Operating Income vs. EBITDA: Understanding the difference is critical when eliminating intersegment transactions, as the impact on each metric differs.
• Spin-Off Economics: The study of how spinoffs affect valuations when intersegment transactions cease and segments must operate independently.

Summary

Inter-segment transactions are a critical component of conglomerate financial statements and a frequent source of error in SOTP valuations. The company discloses them in the segment footnote; your job is to understand their nature, determine whether they would continue post-spin (and at what price), and adjust segment revenues and costs accordingly. The goal is to arrive at a segment-level financial picture that reflects economic reality if the segment operated as a standalone public company.

The process requires both mechanical diligence (ensuring that revenue and cost eliminations are consistent) and strategic judgment (determining whether a transaction is a true synergy or a market-rate transaction that would continue post-spin). Get this step wrong, and your SOTP valuation will be unreliable.

Next

Lost Synergies Post-Spin